HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Otorrhea bacterial profile, epidemiology before widespread use of the third-generation pneumococcal conjugate vaccine in French children, a prospective study from 2015 to 2023.

AbstractOBJECTIVES:
The aim of this study was to describe the bacterial profile of middle ear fluid from spontaneous perforation of the tympanic membrane (SPTM) prior to widespread utilization of third- generation pneumococcal conjugate vaccines (PCVs).
PATIENTS AND METHODS:
From October 2015 to January 2023, children with SPTM were prospectively enrolled by pediatricians.
RESULTS:
Among the 852 children with SPTM, 73.2% were less than 3 years old; more frequently than older children, they were and suffering from complex acute otitis media (AOM) (27.9%) and conjunctivitis (13.1%). In children under 3 years of age, NT Haemophilus influenzae (49.7%) was the main otopathogen isolated, particularly in those with complex AOM (57.1%). In children over 3 years of age, Group A Streptococcus accounted for 57%. In pneumococcal cases (25.1%), serotype 3 was the main serotype isolated (16.2%), followed by 23B (15.2%).
CONCLUSION:
Our data from 2015 to 2023 represent a robust baseline preceding the widespread utilization of next-generation PCVs.
AuthorsCorinne Levy, Emmanuelle Varon, Philippe Bidet, Stéphane Béchet, Christophe Batard, Alain Wollner, Franck Thollot, Stéphane Bonacorsi, Robert Cohen
JournalInfectious diseases now (Infect Dis Now) Vol. 53 Issue 6 Pg. 104738 (Sep 2023) ISSN: 2666-9919 [Electronic] France
PMID37331698 (Publication Type: Journal Article)
CopyrightCopyright © 2023 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Chemical References
  • Vaccines, Conjugate
Topics
  • Humans
  • Child
  • Child, Preschool
  • Adolescent
  • Vaccines, Conjugate
  • Prospective Studies
  • Otitis Media (epidemiology, prevention & control, microbiology)
  • Streptococcus pneumoniae
  • Bacteria

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: